Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-05-18 Option Award | 2021-05-20 7:12 pm | 2022-05-18 2031-05-18 | Hepion Pharmaceuticals Inc. | HEPA | Lippa Arnold Director | 200,000 | $0 | 291,110 (Direct) | View |
| 2020-09-30 Other | 2020-10-02 3:47 pm | 2020-09-30 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman & CSO | 100 | $0 | 100 (Direct) | View |
| 2020-09-30 Gift | 2020-10-02 3:47 pm | 2020-09-30 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman & CSO | 200 | $0 | 100 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-21 4:17 pm | 2021-08-19 2030-08-19 | Hepion Pharmaceuticals Inc. | HEPA | Lippa Arnold Director | 30,000 | $0 | 91,110 (Direct) | View |
| 2020-07-13 Other | 2020-07-15 9:14 pm | 2020-07-13 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman, CEO & CSO | 600 | $0 | 600 (Direct) | View |
| 2020-07-13 Gift | 2020-07-15 9:14 pm | 2020-07-13 2023-09-30 | RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman, CEO & CSO | 1,200 | $0 | 600 (Direct) | View |
| 2020-04-03 Option Award | 2020-04-07 4:14 pm | 2021-04-03 2030-04-03 | Hepion Pharmaceuticals Inc. | HEPA | Lippa Arnold Director | 60,000 | $0 | 61,109 (Direct) | View |
| 2020-03-22 Other | 2020-03-24 4:20 pm | N/A N/A | RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman, CEO, CSO | 4,500,000 | $0 | 4,500,598 (Direct) | View |
| 2020-03-22 Gift | 2020-03-24 4:20 pm | N/A N/A | RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman, CEO, CSO | 4,500,000 | $0 | 4,500,598 (Direct) | View |